US 8513230
Nuclear transport modulators and uses thereof
granted A61KA61K31/4196A61K31/433
Quick answer
US patent 8513230 (Nuclear transport modulators and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Karyopharm Therapeutics Inc.
- Grant date
- Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/4196, A61K31/433, A61K31/4439, A61K31/444